Bottleneck Radar

Where should research start?

Candidates are ranked by structural bottleneck evidence, financial conversion, repricing state, and explicit blockers. Valuation gaps are shown as unresolved research risk.

As-of month

2018-01-31

Universe

1,251 tickers

Strict covered

Source blocked

1,251

Bottleneck and market reflection map

Y-axis is structural score, X-axis is repricing state. Hollow markers indicate valuation is unverified.

Bottleneck scoreMarket repricing state

Inspector

Selected candidate summary

NTRA

Natera, Inc. - Common Stock

Repricing Detected

2 strict familiesValuation Unverified

Structural bottleneck96

Evidence readiness97

Financial conversion67

Primary blockers

No primary blocker recorded

Open dossier

Candidate table

Rows update the inspector; ticker links open the company dossier.

Rank	Company	Structural	Evidence	Financial	Market repricing	Valuation	Primary blocker
1	Natera, Inc. - Common Stock	96	sec, government_contract	67	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
2	Viavi Solutions Inc. - Common Stock	95	sec, government_contract	95	Repricing Detected	Valuation Unverified	Valuation source missing
3	Moderna	95	sec, government_contract	95	Repricing Detected	Valuation Unverified	Valuation source missing
4	Micron Technology	94	sec, government_contract	94	Repricing Detected	Valuation Unverified	Valuation source missing
5	CorMedix Inc. - Common Stock	94	sec, government_contract	96	Structured signal	Valuation Unverified	Valuation source missing
6	Lexicon Pharmaceuticals, Inc. - Common Stock	94	sec, government_contract	98	Repricing Detected	Valuation Unverified	Valuation source missing
7	MACOM Technology Solutions Holdings, Inc. - Common Stock	94	sec, government_contract	92	Repricing Detected	Valuation Unverified	Valuation source missing
8	Beam Therapeutics Inc. - Common Stock	94	sec, government_contract	96	Repricing Detected	Valuation Unverified	Valuation source missing
9	Insmed Incorporated - Common Stock	94	sec	94	Structured signal	Valuation Unverified	Valuation source missing
10	Alphabet Inc. (Class A)	94	sec, government_contract	93	Repricing Detected	Valuation Unverified	Valuation source missing
11	Quantum Computing Inc. - Common Stock	93	sec, government_contract	100	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
12	Applied Materials	93	sec, government_contract	92	Repricing Detected	Valuation Unverified	Valuation source missing
13	Insulet Corporation	93	sec, government_contract	87	Structured signal	Valuation Unverified	Valuation source missing
14	Apple Inc.	93	sec, government_contract	93	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
15	Rocket Lab Corporation - Common Stock	93	sec, government_contract	86	Repricing Detected	Valuation Unverified	Valuation source missing
16	Incyte	93	sec, government_contract	72	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
17	Honeywell	93	sec, government_contract	58	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
18	Cisco	92	sec, government_contract, research	87	Repricing Detected	Valuation Unverified	Valuation source missing
19	Advanced Micro Devices	92	sec, research	86	Repricing Detected	Valuation Unverified	Valuation source missing
20	AtriCure, Inc. - Common Stock	92	sec, government_contract	80	Structured signal	Valuation Unverified	Valuation source missing
21	Palantir Technologies	92	government_contract	92	Structured signal	Valuation Unverified	Valuation source missing
22	Cytokinetics, Incorporated - Common Stock	91	sec, government_contract	98	Repricing Detected	Valuation Unverified	Valuation source missing
23	Crinetics Pharmaceuticals, Inc. - Common Stock	91	sec, government_contract	99	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
24	Intuitive Surgical	91	sec, government_contract	88	Structured signal	Valuation Unverified	Valuation source missing
25	Tetra Tech, Inc. - Common Stock	91	sec, government_contract	88	Structured signal	Valuation Unverified	Valuation source missing
26	Arbutus Biopharma Corporation - Common Stock	91	sec	100	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
27	Liquidia Corporation - Common Stock	91	sec, government_contract	99	Repricing Detected	Valuation Unverified	Valuation source missing
28	4D Molecular Therapeutics, Inc. - Common Stock	91	sec, government_contract	100	Repricing Detected	Valuation Unverified	Valuation source missing
29	GeneDx Holdings Corp. - Class A Common Stock	91	sec	79	Structured signal	Valuation Unverified	Valuation source missing
30	Twin Disc, Incorporated - Common Stock	91	sec, government_contract	94	Repricing Detected	Valuation Unverified	Valuation source missing
31	Precigen, Inc. - Common Stock	91	sec, government_contract	98	Repricing Detected	Valuation Unverified	Valuation source missing
32	Richardson Electronics, Ltd. - Common Stock	91	sec, government_contract	93	Repricing Detected	Valuation Unverified	Valuation source missing
33	Teradyne	90	sec, government_contract	91	Repricing Detected	Valuation Unverified	Valuation source missing
34	PTC Inc.	90	sec, government_contract	93	Structured signal	Valuation Unverified	Valuation source missing
35	Texas Instruments	90	sec, government_contract	87	Repricing Detected	Valuation Unverified	Valuation source missing
36	Precision BioSciences, Inc. - Common Stock	90	sec	100	Repricing Detected	Valuation Unverified	Valuation source missing
37	AngioDynamics, Inc. - Common Stock	90	sec, clinical_trials	95	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
38	Aligos Therapeutics, Inc. - Common stock	90	sec, government_contract	98	Structured signal	Valuation Unverified	Valuation source missing
39	Nvidia	90	sec	96	Emerging Repricing Signal	Valuation Unverified	Valuation source missing
40	Intel	89	sec, government_contract	65	Repricing Detected	Valuation Unverified	Valuation source missing

1,251

High score + Evidence family gap

1,251

Potentially hidden + Valuation missing

Valuation context available

1,251

Source blocked rows